Drug Product Pipeline Resources
Your gateway to tomorrow's medications, treatments, and cures.
AMCP and Apperture are proud to present the AMCP Drug Product Pipeline, the latest innovation in providing access and insight into the formulary decision-making process. Designed to alleviate the workloads of pharmacy benefit managers and health care decision makers, the Pipeline aggregates data from government databases as well as other publicly available sources to provide a one-stop portal featuring the next generation of pharmaceuticals.
The Pipeline showcases the clinical trials currently underway from the top 75 biopharmaceutical companies in the U.S., focusing on medications that are in Phase II/III and Phase III. This new product will provide users with insight into the latest pharmaceuticals that will impact their managed care practice and patient's health over the next five years.
AMCP and Apperture have made two versions of the Pipeline available for use:
- Drug Product Pipeline Portal (Limited View) — This view provides a snapshot of the Pipeline's metrics; a topline description of the types of studies, their statuses, and their proposed end dates; and new trial recruitment broken down by sponsors or conditions.
- Drug Product Pipeline Portal (Member View) — This is the most comprehensive view available in the Drug Product Pipeline. Users will get all of the access from the non-member view, plus the additional ability to filter data by specific categories, manipulate data in tables, view specific clinical trials on government databases, and perform a deep-dive into different figures and statistics.
Want access to the Member View? Sign up for AMCP Membership now!